Announcements Trials
Browse Landscape

Phase

Phase 2 3Phase NA 1Phase 4 1Phase 1/2 1

Status

Terminated 3Completed 3

Sponsor Class

OTHER 5INDUSTRY 1

Study Type

Interventional 6

Sponsor

Cancer Type

CNS 3Other hematologic neoplasm 2Lymphoid 2Myeloid 1

Conditions

Leukemia, Myeloid, Acute 2Brain Neoplasms 2Seizures 1Precursor Cell Lymphoblastic Leukemia-Lymphoma 1Neuroblastoma 1Myelodysplastic Syndromes 1Lymphoma, Large B-Cell, Diffuse 1Glioma 1

Interventions

Cyclophosphamide 909Carboplatin 787pembrolizumab 744Paclitaxel 742Cisplatin 709Bevacizumab 706Gemcitabine 619Docetaxel 579Rituximab 548Radiotherapy 541Dexamethasone 511Nivolumab 488Doxorubicin 444Fluorouracil 392Capecitabine 376Etoposide 358Pemetrexed 337Cytarabine 335Oxaliplatin 333Lenalidomide 328Prednisone 326fludarabine phosphate 316Erlotinib Hydrochloride 314Trastuzumab 300Leucovorin 299fludarabine 296Vincristine 287Filgrastim 284Bortezomib 284Cetuximab 276

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

6 trials
RecentStart dateEnrollment
Interventional × Has results × Levetiracetam × Clear all
NCT01857934 2026-04-16

Therapy for Children With Advanced Stage Neuroblastoma

St. Jude Children's Research Hospital

Phase 2 Completed
153 enrolled 12 charts
CNS

Neuroblastoma

NCT02348216 2024-06-04

ZUMA-1

Gilead Sciences

Phase 1/2 Completed
307 enrolled 41 charts
Lymphoid

Lymphoma, Large B-Cell, Diffuse

NCT03436433 2023-04-13

Seizure Prophylaxis in Patients With Glioma or Brain Metastasis

Duke University

Phase 2 Terminated
4 enrolled 8 charts
CNS

Brain Neoplasms, Glioma

NCT02334722 2021-12-15

1 Week Versus 6 Weeks of Levetiracetam in Surgical Brain Tumor Patients

University of Florida

Phase 4 Completed
81 enrolled 10 charts
CNS

Brain Neoplasms, Seizures

NCT01685411 2021-04-13

Busulfan and Cyclophosphamide Followed By ALLO BMT

Masonic Cancer Center, University of Minnesota

Phase NA Terminated
5 enrolled 16 charts
LymphoidMyeloidOther hematologic neoplasm

Myelodysplastic Syndromes, Leukemia, Myeloid, Acute, Precursor Cell Lymphoblastic Leukemia-Lymphoma

NCT01464359 2017-12-28

T-Cell Depleted Double UCB for Refractory AML

Masonic Cancer Center, University of Minnesota

Phase 2 Terminated
3 enrolled 9 charts
Other hematologic neoplasm

Leukemia, Myeloid, Acute

Data powered by HemOnc (CC BY 4.0) Colophon âš¡